CN Stock MarketDetailed Quotes
688606 Hangzhou Alltest Biotech
- 52.50
- +1.69+3.33%
Market Closed Aug 30 15:00 CST
4.16BMarket Cap17.85P/E (TTM)
52.50High50.60Low4.36KlotVolume50.71Open50.81Pre Close22.66MTurnover1.10%Turnover Ratio23.05P/E (Static)79.28MShares79.6352wk High1.09P/B2.08BFloat Cap45.1752wk Low60.97Limit Up39.55MShs Float149.54Historical High40.65Limit Down3.74%Amplitude44.55Historical Low1.50Dividend TTM51.94Avg Price1.40KlotAsk2.86%Div YieldTTM100Lot Size2.36KlotBid
Hangzhou Alltest Biotech Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.23%396.5M | -15.34%199.92M | -77.73%754.7M | -81.40%559.94M | -85.76%387.85M | -88.75%236.14M | 80.88%3.39B | 201.96%3.01B | 328.52%2.72B | 628.17%2.1B |
| Operating revenue | 2.23%396.5M | -15.34%199.92M | -77.73%754.7M | -81.40%559.94M | -85.76%387.85M | -88.75%236.14M | 80.88%3.39B | 201.96%3.01B | 328.52%2.72B | 628.17%2.1B |
| Total operating cost | -10.78%272.93M | -19.44%144.14M | -66.17%592.08M | -68.81%437.85M | -73.52%305.91M | -77.30%178.93M | 73.28%1.75B | 213.10%1.4B | 347.60%1.16B | 592.03%788.2M |
| Operating cost | -13.86%178.39M | -10.73%99.7M | -71.53%386.54M | -73.04%291.66M | -77.73%207.1M | -83.44%111.69M | 61.64%1.36B | 232.59%1.08B | 411.45%929.81M | 714.02%674.49M |
| Operating tax surcharges | 37.89%3.58M | 28.80%2.05M | -74.71%7.04M | -81.79%3.7M | -81.94%2.6M | -4.97%1.59M | 180.28%27.82M | 66.65%20.33M | 140.14%14.37M | -26.30%1.67M |
| Operating expense | -7.95%30.05M | -35.15%10.81M | -53.91%69.29M | -64.18%47.45M | -68.30%32.64M | -60.92%16.67M | 202.12%150.34M | 338.21%132.46M | 465.45%102.98M | 598.56%42.67M |
| Administration expense | -12.56%30.14M | -25.74%13.49M | -14.70%66.59M | -25.79%48.45M | -11.59%34.46M | -10.72%18.17M | 138.61%78.06M | 154.18%65.29M | 102.79%38.98M | 203.58%20.35M |
| Financial expense | 50.00%-18.39M | 4.59%-5.08M | 17.47%-58.54M | 22.50%-43.11M | -19.01%-36.77M | -344.00%-5.32M | -300.76%-70.93M | -393.75%-55.62M | -496.50%-30.9M | 217.24%2.18M |
| -Interest expense (Financial expense) | -68.71%260.84K | -70.04%132.56K | -33.28%1.45M | -35.03%1.17M | -32.15%833.66K | -41.46%442.38K | 224.69%2.17M | --1.8M | --1.23M | --755.67K |
| -Interest Income (Financial expense) | 19.82%-17.48M | 36.50%-5.37M | 16.95%-35.62M | 9.24%-29.49M | -37.90%-21.8M | -104.40%-8.45M | -13.14%-42.89M | -75.79%-32.49M | -11.59%-15.81M | -840.22%-4.13M |
| Research and development | -25.38%49.16M | -35.89%23.16M | -41.55%121.17M | -43.72%89.69M | -34.08%65.88M | -22.89%36.12M | 117.16%207.3M | 140.80%159.38M | 162.69%99.94M | 162.93%46.84M |
| Credit Impairment Loss | -13.89%-12.26M | -45.58%-11.37M | -102.06%-11.23M | -103.75%-14.11M | -72.34%-10.77M | -85.30%-7.81M | 17.91%-5.56M | -281.11%-6.93M | -110.04%-6.25M | -48.54%-4.21M |
| Asset Impairment Loss | -275.45%-8.39M | 68.09%-5.44M | 102.00%5.6M | 101.48%1.05M | 106.72%4.78M | 76.00%-17.06M | -7,016.09%-280.06M | -4,577.25%-71.08M | -1,870.70%-71.08M | -5,762.74%-71.08M |
| Other net revenue | ||||||||||
| Fair value change income | 797.97%12.66M | -64.70%3.36M | 314.66%32.67M | -83.25%4.96M | -90.61%1.41M | --9.53M | -171.36%-15.22M | --29.63M | --15.01M | ---- |
| Invest income | 46.95%9.21M | -9.77%4.2M | -64.20%8.63M | -56.10%6.34M | -49.29%6.26M | 61.98%4.66M | 246.83%24.12M | 114.33%14.45M | 130.20%12.35M | -23.56%2.88M |
| Asset deal income | 724.52%3.34M | 99.28%-6.08K | -178.63%-419.22K | -3,438.20%-535.17K | -489,844.80%-535.17K | -774,917.52%-846.55K | 1,004.34%533.17K | -44.92%16.03K | -100.38%-109.23 | -100.38%-109.23 |
| Other revenue | 74.27%13.92M | 38.25%796.95K | -56.82%13.71M | -64.22%9.3M | -56.58%7.99M | -85.47%576.47K | 99.67%31.75M | 372.85%26M | 371.73%18.4M | 1,484.45%3.97M |
| Operating profit | 55.97%142.05M | 2.32%47.33M | -84.82%211.58M | -91.92%129.1M | -94.07%91.08M | -96.28%46.25M | 55.43%1.39B | 185.14%1.6B | 304.20%1.54B | 612.55%1.24B |
| Add:Non operating Income | 1,186.18%179.74K | 11,774.39%100K | -80.76%24.08K | -98.54%13.97K | -95.06%13.97K | -99.47%842.15 | 114.87%125.17K | 2,573.07%957.06K | 314,461,866.67%283.02K | 263,909,500.00%158.35K |
| Less:Non operating expense | -77.72%3.08M | 35.77%271.7K | 13.29%14.17M | 45.09%14.15M | 48.33%13.83M | -96.34%200.11K | 879.44%12.51M | 688.68%9.75M | 817.50%9.32M | 547,267,166.00%5.47M |
| Total profit | 80.10%139.15M | 2.39%47.16M | -85.71%197.44M | -92.77%114.96M | -94.94%77.26M | -96.28%46.06M | 54.26%1.38B | 184.18%1.59B | 302.90%1.53B | 609.50%1.24B |
| Less:Income tax cost | 142.62%15.61M | -56.06%2.51M | -91.25%17.16M | -94.01%13.72M | -97.14%6.44M | -96.95%5.72M | 50.94%195.99M | 197.07%228.93M | 323.76%224.93M | 680.56%187.83M |
| Net profit | 74.42%123.53M | 10.68%44.64M | -84.79%180.28M | -92.56%101.25M | -94.56%70.83M | -96.16%40.34M | 54.82%1.19B | 182.12%1.36B | 299.51%1.3B | 598.12%1.05B |
| Net profit from continuing operation | 74.42%123.53M | 10.68%44.64M | -84.79%180.28M | -92.56%101.25M | -94.56%70.83M | -96.16%40.34M | 54.82%1.19B | 182.12%1.36B | 299.51%1.3B | 598.12%1.05B |
| Less:Minority Profit | 2.86%-344.83K | 26.37%-144.58K | -154.94%-295.58K | -283.53%-319.37K | -506.30%-355K | -120.88%-196.37K | --538.05K | --174.02K | --87.37K | ---88.9K |
| Net profit of parent company owners | 74.03%123.88M | 10.50%44.79M | -84.76%180.58M | -92.53%101.57M | -94.54%71.18M | -96.14%40.53M | 54.75%1.18B | 182.09%1.36B | 299.48%1.3B | 598.18%1.05B |
| Earning per share | ||||||||||
| Basic earning per share | 73.33%1.56 | 9.80%0.56 | -84.75%2.28 | -92.54%1.28 | -94.52%0.9 | -97.38%0.51 | -1.32%14.95 | 79.31%17.16 | 137.43%16.43 | 423.12%19.46 |
| Diluted earning per share | 73.33%1.56 | 9.80%0.56 | -84.75%2.28 | --1.28 | --0.9 | --0.51 | --14.95 | ---- | ---- | ---- |
| Other composite income | -86.37%648.53K | 153.93%151.35K | -91.58%2.37M | -86.50%3.88M | -66.90%4.76M | -410.05%-280.66K | 21,705.78%28.12M | 16,975.15%28.78M | 24,772.44%14.38M | 3,247.81%90.52K |
| Other composite income of parent company owners | -86.58%637.99K | 142.57%144.61K | -91.60%2.36M | -86.52%3.88M | -66.93%4.75M | -464.00%-339.7K | 21,710.09%28.13M | 16,983.33%28.79M | 24,772.44%14.38M | 3,345.32%93.32K |
| Other composite income of minority owners | 149.32%10.55K | -88.58%6.74K | 180.83%4.5K | 119.25%2.65K | --4.23K | 2,205.68%59.05K | ---5.56K | ---13.79K | ---- | ---2.8K |
| Total composite income | 64.30%124.18M | 11.83%44.8M | -84.95%182.65M | -92.43%105.13M | -94.26%75.59M | -96.18%40.06M | 58.47%1.21B | 187.99%1.39B | 303.85%1.32B | 598.20%1.05B |
| Total composite income of parent company owners | 63.98%124.52M | 11.79%44.93M | -84.92%182.94M | -92.41%105.45M | -94.23%75.94M | -96.17%40.19M | 58.40%1.21B | 187.96%1.39B | 303.82%1.32B | 598.26%1.05B |
| Total composite income of minority owners | 4.70%-334.28K | -0.37%-137.84K | -154.67%-291.09K | -297.67%-316.72K | -501.46%-350.77K | -49.74%-137.33K | --532.49K | --160.23K | --87.37K | ---91.71K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg